NAD and Glutathione Together: Clinical Evidence

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD (nicotinamide adenine dinucleotide) and glutathione are endogenous molecules involved in energy metabolism and cellular antioxidant defense, respectively. Both decline with age, and some research suggests combined support may offer complementary effects on mitochondrial function and oxidative stress.

The appeal of combining these compounds lies in their synergistic roles in cellular health. However, individual response depends on baseline biomarker status, genetic predispositions, and overall metabolic health—factors that warrant personalized assessment rather than a generalized approach.

How NAD and Glutathione Function at the Cellular Level

NAD serves as a coenzyme in hundreds of metabolic reactions, particularly in mitochondrial energy production via sirtuins and PARP enzymes. Glutathione, the cell's primary antioxidant, neutralizes reactive oxygen species and supports Phase II detoxification pathways. Together, they may address both energy availability and oxidative burden.

NAD levels naturally decline approximately 50 percent by age 60, correlating with reduced mitochondrial efficiency. Glutathione depletion accelerates in response to chronic stress, inflammation, and environmental toxins. Understanding whether your baseline levels are compromised is essential before determining if supplementation is warranted.

Biomarker Assessment and Baseline Status Matter

Before considering NAD and glutathione support, baseline measurement of these molecules—through blood work, saliva panels, or mitochondrial function tests—can reveal whether depletion is actually present. Without biomarker context, supplementation may represent unnecessary expense and potential metabolic interference rather than targeted intervention.

Biomarker / Assessment	What It Indicates
NAD+ blood or saliva levels	Direct measurement of NAD availability; low levels correlate with age-related mitochondrial decline
Glutathione (plasma or RBC)	Antioxidant capacity and detoxification reserve; low levels suggest oxidative stress burden
Mitochondrial function testing	ATP production efficiency; indicates whether energy production is truly compromised
Oxidative stress markers (8-OHdG, malondialdehyde)	Extent of cellular damage; helps determine if antioxidant support is therapeutically justified
Lactate and pyruvate ratio	Marker of mitochondrial efficiency; elevated ratio suggests impaired NAD-dependent metabolism

Clinical Evidence: What the Research Actually Shows

Human clinical trials on NAD supplementation remain limited. Most evidence comes from animal models or cellular studies showing improved mitochondrial function. A 2021 randomized trial in humans found that oral NAD precursor (NMN) improved insulin sensitivity in obese women, but large-scale studies are lacking.

Glutathione supplementation faces absorption challenges since the tripeptide is broken down in the digestive tract. Oral glutathione shows minimal bioavailability unless stabilized or liposomal. Intravenous administration has stronger mechanistic support but requires clinical infrastructure and carries infusion risks that warrant provider oversight.

Safety Considerations and Who Should Seek Provider Guidance

NAD precursors (NMN, NR) are generally well-tolerated at standard doses, though some users report mild nausea or headache. Long-term safety in humans remains understudied. Glutathione, when taken orally, poses minimal direct risk but may interact with sulfur-dependent pathways in susceptible individuals or those with certain genetic variants affecting detoxification.

Individuals with active cancer, sirtuin-related conditions, or those taking medications targeting NAD pathways should consult a provider before starting either compound. Pregnant women, those with severe liver or kidney disease, and people on blood thinners should seek medical clearance. A qualified healthcare provider can assess whether biomarker data and personal health status support use.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and detoxification pathways that can provide context for NAD and glutathione metabolism. Variants in genes affecting mitochondrial efficiency and oxidative stress response may help explain individual variation in baseline NAD and glutathione status and how these molecules are metabolized.

The genetic test does not predict exact NAD or glutathione response, nor does it diagnose mitochondrial disease or oxidative stress. Rather, it may help provide context about your genetic predisposition to metabolic inefficiency or higher antioxidant demand, which should be interpreted with a qualified healthcare provider alongside biomarker measurements.

Combining genetic insights with clinical biomarker data—such as NAD levels, glutathione status, and markers of mitochondrial function—enables a more personalized conversation with your provider about whether combined NAD and glutathione support aligns with your individual health picture and therapeutic goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I take NAD and glutathione together safely?

Both compounds are generally well-tolerated at standard doses, but long-term human safety data is limited. A qualified healthcare provider should assess your personal health status, medications, and biomarker context before recommending combined use.

What does clinical research actually show about NAD and glutathione together?

Limited human studies exist on the combination. Most evidence comes from animal models or small trials. A 2021 study found NMN (NAD precursor) improved insulin sensitivity, but larger randomized trials are needed to establish efficacy and optimal dosing in humans.

How do I know if my NAD and glutathione levels are actually low?

Blood or saliva biomarker testing can measure NAD and glutathione directly. Mitochondrial function tests and oxidative stress markers (8-OHdG, MDA) provide additional context. Without baseline measurement, supplementation may not address an actual deficiency.

Does PlexusDx test for NAD or glutathione levels?

The Precision Peptide Genetic Test reveals genetic predispositions in metabolic and detoxification pathways, not direct NAD or glutathione measurements. PlexusDx recommends biomarker testing through your healthcare provider to assess actual NAD and glutathione status before considering supplementation.

Does genetic testing predict whether NAD and glutathione will help me?

The Precision Peptide Genetic Test ($99 add-on, $298 standalone) identifies genetic predispositions in mitochondrial and detoxification pathways that may contextualize your metabolic profile. However, genetics does not predict exact response to NAD or glutathione supplementation. Biomarker data and provider assessment are essential for personali...

NAD and Glutathione Together: Biomarker Context and Clinical Evidence

NAD and glutathione are molecules that work in cellular energy production and antioxidant defense. While often discussed together in wellness contexts, clinical evidence remains limited.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →